EIKN — EIKON THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 82 家机构在其最新 13F 申报中持有 EIKN(EIKON THERAPEUTICS INC),合计申报市值 $368.62M,对应 29.37M 股。按股数计算较上季度增持 10.3%(+2.57M 股),申报市值环比上升 35.7%。持仓集中度较高:前五大持有人占申报市值的 51.3%,前十大的集中度为 71.1%。
与上一季度相比,39 家新建仓位、19 家加仓、10 家减仓、14 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
EIKON THERAPEUTICS INC(EIKN)的主要机构持有人包括 Fidelity Management & Research (FMR)、BlackRock Inc、Foresite Capital Management IV, LLC,按 13F 申报市值在本页 119 家持有人中排名居前。
EIKN 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 63 | 19.81M | $158.67M | +17.4% |
| Q2 2026 | 82 | 29.37M | $368.62M | +10.3% |
| Q1 2026 | 57 | 26.35M | $268.52M | — |
| Q1 2025 | 3 | 2.85K | $34.05K | -96.0% |
| Q4 2024 | 3 | 71.20K | $799.08K | +225.7% |
| Q3 2024 | 3 | 21.86K | $439.29K | +15.6% |
| Q2 2024 | 3 | 18.91K | $617.00K | -69.9% |
| Q1 2024 | 3 | 62.87K | $610.46K | +169.2% |
表内 8 个季度中,机构持股合计增加 31403%(Q1 2024 → Q3 2026);单季变动最大的是 Q4 2024(+225.7%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 5.52M | $44.38M | 0.00% | 增持 | |
| 4.87M | $39.15M | 0.00% | 增持 | |
| 1.67M | $13.40M | 1.63% | 持有 | |
| 1.18M | $9.45M | 0.00% | 持有 | |
| 1.02M | $8.16M | 0.00% | 增持 | |
| 754.50K | $6.07M | 0.00% | 增持 | |
| 635.13K | $5.11M | 0.12% | 新进 | |
| 608.84K | $4.90M | 0.00% | 增持 | |
| 484.67K | $3.90M | 2.14% | 持有 | |
| 391.27K | $3.15M | 0.02% | 新进 | |
| 298.00K | $2.40M | 0.11% | 增持 | |
| 278.90K | $2.24M | 0.00% | 增持 | |
| 350.00K | $2.24M | 0.00% | 持有 | |
| 247.11K | $1.99M | 0.00% | 增持 | |
| 223.02K | $1.79M | 0.00% | 增持 | |
| 202.24K | $1.63M | 0.00% | 增持 | |
| 142.50K | $1.15M | 0.00% | 减持 | |
| 137.41K | $1.10M | 0.00% | 增持 | |
| 134.50K | $1.08M | 0.00% | 持有 | |
| 71.25K | $572.89K | 0.00% | 增持 | |
| 65.87K | $529.60K | 0.00% | 增持 | |
| 63.83K | $513.19K | 0.00% | 新进 | |
| 56.95K | $450.48K | 0.00% | 增持 | |
| 51.16K | $411.31K | 0.00% | 增持 | |
| 47.94K | $385.46K | 0.11% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q1 2025 — 3 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 354 | $24.59K | 0.10% | 减持 | |
| 1.60K | $6.46K | 0.00% | 减持 | |
| 900 | $3.00K | 0.00% | 减持 |
Q4 2024 — 3 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.80K | $577.28K | 6.19% | 增持 | |
| 46.50K | $148.80K | 0.00% | 增持 | |
| 22.90K | $73.00K | 0.00% | 增持 |
Q3 2024 — 3 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.76K | $394.46K | 0.73% | 减持 | |
| 15.10K | $33.82K | 0.00% | 增持 | |
| 5.00K | $11.00K | 0.00% | 减持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 556.96K 股 · $7.27M
- Parkman Healthcare Partners LLC 256.05K 股 · $3.34M
- Sixth Street Partners Management Company, L.P. 182.10K 股 · $2.38M
- Schonfeld Strategic Advisors LLC 179.78K 股 · $2.35M
- Affinity Asset Advisors, LLC 98.00K 股 · $1.28M
- ALPS ADVISORS INC 54.95K 股 · $717.07K
- Invesco Ltd 50.90K 股 · $664.25K
- BNY Mellon 47.79K 股 · $623.63K
- TCG Crossover Management, LLC 37.90K 股 · $494.62K
- Polen Capital Management 35.74K 股 · $466.43K
- ProShare Advisors LLC 29.68K 股 · $387.39K
- Nuveen, LLC 28.99K 股 · $378.29K
完全清仓(较上季)
- JANE STREET GROUP, LLC 卖出 265.00K 股 · $2.80M
- Wellington Management Group 卖出 185.00K 股 · $1.96M
- WELLINGTON MANAGEMENT GROUP LLP 卖出 185.00K 股 · $1.96M
- Blackstone Inc. 卖出 168.34K 股 · $1.78M
- Goldman Sachs Group 卖出 129.31K 股 · $1.37M
- LMR Partners LLP 卖出 115.00K 股 · $1.22M
- SEVEN GRAND MANAGERS, LLC 卖出 80.00K 股 · $846.40K
- Ghisallo Capital Management LLC 卖出 70.00K 股 · $740.60K
- STATE STREET CORP 卖出 40.15K 股 · $424.79K
- Squarepoint Ops LLC 卖出 30.98K 股 · $327.75K
- AXQ CAPITAL, LP 卖出 15.41K 股 · $163.02K
- Hudson Bay Capital Management LP 卖出 13.48K 股 · $142.62K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 5.52M | 4.99M | 3.84M | — | — | — | — | — | — | — |
| BlackRock Inc | 4.87M | 4.28M | 3.32M | — | — | — | — | — | — | — |
| Merck & Co., Inc. | 1.67M | 1.67M | 1.67M | — | — | — | — | — | — | — |
| Capital World Investors | 1.18M | 1.18M | 1.14M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.02M | 922.71K | 969.43K | — | — | — | — | — | — | — |
| Geode Capital Management | 754.50K | 556.96K | 273.93K | — | — | — | — | — | — | — |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 635.13K | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 608.84K | — | 40.15K | — | — | — | — | — | — | — |
| SOROS CAPITAL MANAGEMENT LLC | 484.67K | 484.67K | 484.67K | — | — | — | — | — | — | — |
| Walleye Capital LLC | 391.27K | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 298.00K | 98.00K | — | — | — | — | — | — | — | — |
| UBS Group AG | 278.90K | 263.93K | 99.41K | — | — | — | — | — | — | — |
| Franklin Resources | 350.00K | 350.00K | 350.00K | — | — | — | — | — | — | — |
| Morgan Stanley | 247.11K | 12.03K | 15.27K | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 223.02K | 148.90K | 13.61K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 202.24K | 148.41K | 131.95K | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 142.50K | 170.49K | 200.00K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 137.41K | 8.51K | — | — | — | — | — | — | — | — |
| BNP Paribas Asset Management Holding S.A. | 134.50K | 134.50K | 140.34K | — | — | — | — | — | — | — |
| ALPS ADVISORS INC | 71.25K | 54.95K | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold EIKN?
As of 2026-Q2, 82 institutional funds reported holding EIKN (EIKON THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $368.62M.
How many shares of EIKN do institutions own?
13F filers reported 29.37M shares of EIKN, worth $368.62M in aggregate at the end of 2026-Q2.
Is institutional ownership of EIKN rising or falling?
Share counts moved +10.3% versus the prior quarter — accumulation.
Who are the top institutional holders of EIKN?
The largest 13F holders are Fidelity Management & Research (FMR), BlackRock Inc, Foresite Capital Management IV, LLC, T. Rowe Price Investment Management, Inc., Foresite Capital Management V, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of EIKON THERAPEUTICS INC?
The major shareholders of EIKON THERAPEUTICS INC (EIKN) by reported 13F value are Fidelity Management & Research (FMR), BlackRock Inc, Foresite Capital Management IV, LLC, T. Rowe Price Investment Management, Inc., Foresite Capital Management V, LLC, among 119 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.